Inspection of Licensed Product Sample Clauses

Inspection of Licensed Product. 3.3.1. Within fifteen (15) business days after Luitpold's receipt of a shipment of the Licensed Products, Luitpold shall inspect the Licensed Products and the documentation accompanying such shipment. Luitpold shall promptly, and in no event more than fifteen (15) business days after receipt of such shipment, notify BMPI of any Defective Licensed Products or error in the documentation and provide a detailed description of the Defective Licensed Products or the error. If Luitpold does not notify BMPI of any Defective Licensed Products or error in the documentation accompanying any shipment within fifteen (15) business days after Luitpold's receipt of a shipment of the Licensed Products, Luitpold shall be deemed to have accepted such shipment.
Sample 1Sample 2
AutoNDA by SimpleDocs
Inspection of Licensed Product. 4.4.1. Upon KEYSTONE DENTAL’s receipt of a shipment of Licensed Product, KEYSTONE DENTAL shall inspect Licensed Product and the documentation accompanying such shipment. KEYSTONE DENTAL shall promptly, but in no event more than ten (10) calendar days after receipt of such shipment, notify the NIBEC of any Defective Licensed Product or error in the documentation and provide a detailed description of the Defective Licensed Product or the error. If KEYSTONE DENTAL does not notify NIBEC of any Defective Licensed Product or error in the documentation accompanying any shipment within ten (10) calendar days after KEYSTONEDENTAL’s receipt of a shipment of Licensed Product, KEYSTONE DENTAL shall be deemed to have accepted such shipment; provided, however, that if any latent defect in the product is discovered after such period, and that defect could not have been discovered by tests and methods available to KEYSTONE DENTAL at the time of receipt, the product shall not be deemed accepted and KEYSTONE DENTAL shall have the remedies specified in this Section 5.3 and by Section 8.
Sample 1Sample 2
Inspection of Licensed Product. MiniMed shall have the right but not the obligation to conduct inspection tests of Licensed Products to be shipped to MiniMed at MRG's facility. Licensed Products reasonably rejected by MiniMed as a result of such inspection shall not be shipped. In the event of any shortage, damage or discrepancy in or to a shipment of Licensed Products or in the event any Licensed Product fails to comply with the then current specification for the Licensed Product, MiniMed will make a written claim within two months from the date of delivery of the Licensed Products for problems that are patent (i.e. readily discoverable from a customary physical inspection of the shipment or MRG's manufacturing records maintained in accordance with applicable regulatory requirements) and as promptly as practicable after discovery for latent defects. MiniMed's claim will detail such shortage, damage or discrepancy or failure and furnish such written evidence or other documentation as MRG reasonably may deem appropriate. If such shortage, damage or discrepancy or non-conformity with specifications existed at the time of delivery of Licensed Product at the F.O.B. point, MiniMed may return the Licensed Product to MRG at MRG's expense except that in no event shall MiniMed be entitled to return any Licensed Product beyond the expiration date for its use if MRG could have corrected the problem had it been discovered within two months after delivery. Upon such return of a Licensed Product and, except as otherwise provided in Section 7, MRG shall at MiniMed's option, either (a) promptly deliver a substitute Licensed Product of the same or another acceptable design to MiniMed in accordance with the delivery procedures set forth herein or (b) refund to MiniMed MiniMed's cost of the Licensed Product including all costs of shipping, handling, insurance, import and export taxes and other similar expenses incurred by MiniMed. In no event shall the provisions of this Section 12.1 limit or otherwise affect MRG's liability for any breach of the warranty set forth in Section 12.2 or for indemnification pursuant to Section 14.7 with respect to any Licensed Product sold or otherwise distributed by MiniMed without knowledge of any defect, failure to meet specifications, damage or other similar problem. MRG shall have no liability for incidental or consequential damages, but in no event shall bodily injury, death or property damage caused by a Licensed Product be deemed to be incidental or consequential damag...
Sample 1Sample 2

Related to Inspection of Licensed Product

  • Marking of Licensed Products To the extent commercially feasible and consistent with prevailing business practices, Company shall xxxx, and shall cause its Affiliates and Sublicensees to xxxx, all Licensed Products that are manufactured or sold under this Agreement with the number of each issued patent under the Patent Rights that applies to such Licensed Product.

  • Licensed Products Lessee will obtain no title to Licensed Products which will at all times remain the property of the owner of the Licensed Products. A license from the owner may be required and it is Lessee's responsibility to obtain any required license before the use of the Licensed Products. Lessee agrees to treat the Licensed Products as confidential information of the owner, to observe all copyright restrictions, and not to reproduce or sell the Licensed Products.

  • Licensed Product “Licensed Product” shall mean any article, composition, apparatus, substance, chemical material, method, process or service whose manufacture, use, or sale is covered or claimed by a Valid Claim within the Patent Rights. For clarity, a “Licensed Product” shall not include other product or material that (a) is used in combination with Licensed Product, and (b) does not constitute an article, composition, apparatus, substance, chemical material, method, process or service whose manufacture, use, or sale is covered or claimed by a Valid Claim within the Patent Rights.

  • License; Use Upon delivery to an Authorized Person or a person reasonably believed by Custodian to be an Authorized Person of the Fund of software enabling the Fund to obtain access to the System (the “Software”), Custodian grants to the Fund a personal, nontransferable and nonexclusive license to use the Software solely for the purpose of transmitting Written Instructions, receiving reports, making inquiries or otherwise communicating with Custodian in connection with the Account(s). The Fund shall use the Software solely for its own internal and proper business purposes and not in the operation of a service bureau. Except as set forth herein, no license or right of any kind is granted to the Fund with respect to the Software. The Fund acknowledges that Custodian and its suppliers retain and have title and exclusive proprietary rights to the Software, including any trade secrets or other ideas, concepts, know-how, methodologies, or information incorporated therein and the exclusive rights to any copyrights, trademarks and patents (including registrations and applications for registration of either), or other statutory or legal protections available in respect thereof. The Fund further acknowledges that all or a part of the Software may be copyrighted or trademarked (or a registration or claim made therefor) by Custodian or its suppliers. The Fund shall not take any action with respect tot the Software inconsistent with the foregoing acknowledgement, nor shall the Fund attempt to decompile, reverse engineer or modify the Software. The Fund may not xxx, sell, lease or provide, directly or indirectly, any of the Software of any portion thereof to any other person or entity without Custodian’s prior written consent. The Fund may not remove any statutory copyright notice or other notice included in the Software or on any media containing the Software. The Fund shall reproduce any such notice on any reproduction of the Software and shall add any statutory copyright notice or other notice to the Software or media upon Custodian’s request.

  • Licensed Territory Worldwide NIH Patent License Agreement—Exclusive APPENDIX C – ROYALTIES Royalties:

  • Licensed Technology The term "Licensed Technology" shall mean the ------------------- Licensed Patents, plus all improvements thereto developed by Licensor, and all related data, know-how and technology.

  • Supply of Materials Unless the parties otherwise agree in a Work Order, Manufacturer will supply, in accordance with the relevant approved raw material specifications, all materials to be used by Manufacturer in the performance of Services under a Work Order other than the Rhythm Materials specified in such Work Order. Rhythm or its designees will provide Manufacturer with the Rhythm Materials. Manufacturer agrees (a) to account for all Rhythm Materials, (b) not to provide Rhythm Materials to any third party (other than an Affiliate acting as a permitted subcontractor) without the express prior written consent of Rhythm, (c) not to use Rhythm Materials for any purpose other than conducting the Services, including, without limitation, not to analyze, characterize, modify or reverse engineer any Rhythm Materials or take any action to determine the structure or composition of any Rhythm Materials unless required * CONFIDENTIAL TREATMENT REQUESTED. OMITTED PORTIONS FILED WITH THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO RULE 406 PROMULGATED UNDER THE SECURITIES ACT OF 1933, AS AMENDED. pursuant to a signed Work Order, and (d) to destroy or return to Rhythm all unused quantities of Rhythm Materials according to Rhythm’s written directions.

  • Product The term “

  • Manufacture (a) Manufacturer shall only manufacture the specific number of Products as requested by Company and at no time shall manufacture excess goods or overruns. Manufacturer shall not sell any Products bearing the Trademarks to any third parties without the express written consent of Company.

  • Sublicense to Use the Xxxxxxx Trademarks As exclusive licensee of the rights to use and sublicense the use of the "Xxxxxxx," "Xxxxxxx Xxxxxx Investments, Inc." and "Xxxxxxx, Xxxxxxx & Xxxxx, Inc." trademarks (together, the "Xxxxxxx Marks"), you hereby grant the Trust a nonexclusive right and sublicense to use (i) the "Xxxxxxx" name and xxxx as part of the Trust's name (the "Fund Name"), and (ii) the Xxxxxxx Marks in connection with the Trust's investment products and services, in each case only for so long as this Agreement, any other investment management agreement between you and the Trust, or any extension, renewal or amendment hereof or thereof remains in effect, and only for so long as you are a licensee of the Xxxxxxx Marks, provided however, that you agree to use your best efforts to maintain your license to use and sublicense the Xxxxxxx Marks. The Trust agrees that it shall have no right to sublicense or assign rights to use the Xxxxxxx Marks, shall acquire no interest in the Xxxxxxx Marks other than the rights granted herein, that all of the Trust's uses of the Xxxxxxx Marks shall inure to the benefit of Xxxxxxx Trust Company as owner and licensor of the Xxxxxxx Marks (the "Trademark Owner"), and that the Trust shall not challenge the validity of the Xxxxxxx Marks or the Trademark Owner's ownership thereof. The Trust further agrees that all services and products it offers in connection with the Xxxxxxx Marks shall meet commercially reasonable standards of quality, as may be determined by you or the Trademark Owner from time to time, provided that you acknowledge that the services and products the Trust rendered during the one-year period preceding the date of this Agreement are acceptable. At your reasonable request, the Trust shall cooperate with you and the Trademark Owner and shall execute and deliver any and all documents necessary to maintain and protect (including but not limited to in connection with any trademark infringement action) the Xxxxxxx Marks and/or enter the Trust as a registered user thereof. At such time as this Agreement or any other investment management agreement shall no longer be in effect between you (or your successor) and the Trust, or you no longer are a licensee of the Xxxxxxx Marks, the Trust shall (to the extent that, and as soon as, it lawfully can) cease to use the Fund Name or any other name indicating that it is advised by, managed by or otherwise connected with you (or any organization which shall have succeeded to your business as investment manager) or the Trademark Owner. In no event shall the Trust use the Xxxxxxx Marks or any other name or xxxx confusingly similar thereto (including, but not limited to, any name or xxxx that includes the name "Xxxxxxx") if this Agreement or any other investment advisory agreement between you (or your successor) and the Fund is terminated.

Time is Money Join Law Insider Premium to draft better contracts faster.